🔴 Azitra is trading 13.91% down in after-hours trading

Azitra is trading at $1.30, down 13.91% in after-hours trading; the announcement did not establish a reason for the decline.

• On October 26, Azitra reported positive ex vivo results for its ATR-COSF cosmetic candidate, including improved wrinkle appearance and skin elasticity.
• Initial first-in-human results are expected by year-end; the company also said it would pause use of its at-the-market offering program for the foreseeable future.
• Azitra’s 1-for-10 reverse split took effect October 26, so the reported close-to-close percentage change is not directly comparable with prior pre-split prices.